Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 13/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | MAOB | P27338 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | MGAM | O43451 | 1/20 | 0.64 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.64 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.64 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | DHODH | Q02127 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | DPP4 | P27487 | 1/20 | 0.59 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.59 |
| ▸ | RELA | Q04206 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xanthohumol SCHEMBL738122 | 1.00 | PDPK1 (1.00) | PDPK1TTRALOX5ABCB1MAPT | |
| Xanthohumol SCHEMBL143683 | 1.00 | PDPK1 (1.00) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL26539037 | 0.97 | PDPK1 (0.93) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL30630210 | 0.97 | PDPK1 (0.93) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL16450254 | 0.92 | PDPK1 (0.86) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL144848 | 0.92 | ABCB1 (0.85) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL16174029 | 0.91 | ABCB1 (0.86) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL26538024 | 0.91 | PDPK1 (0.84) | PDPK1TTRALOX5ABCB1MAPT | |
| SCHEMBL31415696 | 0.91 | PDPK1 (0.84) | PDPK1TTRALOX5ABCB1MAPT | |
| Xanthogalenol SCHEMBL30259154 | 0.91 | PDPK1 (0.84) | PDPK1TTRALOX5ABCB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4499054-A1 | ANTIVIRAL COMPOSITION COMPRISING CHITOSAN AND XANTHOHUMOLONE | Health Plus (FR) | 2025-02-05 | — | — | EP | disclosed |
| US-20250009709-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | INNOX Corp. (US) | 2025-01-09 | — | — | US | disclosed |
| EP-4366723-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | Innox Corp. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023186804-A1 | ANTIVIRAL COMPOSITION COMPRISING CHITOSAN AND XANTHOHUMOLONE | HEALTH PLUS (FR) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023283418-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | INNOX Corp. (US) | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009709-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | CYP46A1, NR1H3, NR1H2 | PDPK1 15/4885TTR 2934/4885ALOX5 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.